RxDoctor Payments Data

William Francis, DO

Family Medicine · Pleasant Grove, UTNPI 1619388998

Payments from drug & device makers

$6,827in general payments, 2019–2025

Across 435 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$683
  • Lilly USA, LLC$443
  • Pfizer$402
  • Takeda Pharmaceuticals U.S.A., Inc.$234
  • Sanofi-aventis U.S. LLC$218
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$6,72899%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,827 in reported general payments places this provider in the 85th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$98,982
Medicare patients
226
Services billed
1,470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide124$181,727
EliquisApixaban55$95,116
OzempicSemaglutide58$65,435
JardianceEmpagliflozin35$48,007
Soliqua 100-33Insulin Glargine/Lixisenatide28$31,492
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog18$27,480
ProliaDenosumab15$26,448
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$23,865
XareltoRivaroxaban14$22,615
ErythromycinErythromycin Base14$5,357
Omeprazole188$3,980
Atorvastatin Calcium341$3,688
Venlafaxine Hcl ErVenlafaxine Hcl12$3,500
Levothyroxine Sodium296$3,427
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$3,274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$443$181,727124 claims
PfizerEliquis$402$95,11655 claims
Novo NordiskOzempic$218$65,43558 claims
Boehringer IngelheimJardiance$94$48,00735 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$218$31,49228 claims
AmgenProlia$683$26,44815 claims
GSKTrelegy Ellipta$96$23,86531 claims
Johnson & JohnsonXarelto$201$22,61514 claims
AbbVieSynthroid$1,457$2,33929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 928 family medicine providers in Utah.

Other family medicine in Pleasant Grove

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →